Illustrative inputs for the educational simulation only.
# Illustrative inputs for the educational simulation only.
# Values are not clinical recommendations and are not attributed to trial protocols.
# Only settings read by this implementation are included.
version: "2026.10-rc1"
hemodynamic_thresholds:
hr_critical_low: 48
map_critical_low: 60
pharmacokinetics:
dexmedetomidine:
# Unvalidated one-central-compartment plus effect-site example.
central_volume_L_per_kg: 0.8
elimination_rate_constant_k10: 0.04
effect_site_transfer_k1e: 0.1
drug_dosing:
# Historical field name retained for compatibility; simulation values only.
dexmedetomidine:
standard_dose: 0.5
geriatric_dose: 0.25
geriatric_age_threshold: 65
ketamine:
standard_dose: 0.2
lidocaine:
standard_dose: 1.5
contraindications:
# Incomplete illustrative string matching, not a clinical contraindication database.
dexmedetomidine:
# Case-insensitive substring match; "Heart Block" also matches "complete heart block".
cardiac_conditions: ["Heart Block", "AV Block", "Mobitz", "Sick Sinus Syndrome", "Severe Bradycardia"]
ketorolac:
egfr_minimum: 30
allergy_triggers: ["NSAID", "Ketorolac", "Aspirin"]
simulation_rate_ceilings:
# Software ceilings, not clinical maxima: the loop zeroes and latches any agent whose
# in-memory rate is negative, non-finite or above these values. Units match drug_dosing
# (dexmedetomidine mcg/kg/h; ketamine and lidocaine mg/kg/h). The lidocaine value matches the
# upper infusion rate in the 2021 international consensus (Foo et al., Anaesthesia 2021;76:238-250),
# which also specifies ideal body weight and a 24 h limit that this simulation does not model.
Dexmedetomidine: 0.5
Ketamine: 0.2
Lidocaine: 1.5
age_adjustments:
geriatric:
age_threshold: 65
Source and scopePublished from Smart-NOA-Controller/config.yaml at revision 477da1e08dca. Full source text is retained; HTML presentation does not establish independent clinical review. In-memory simulation with no patient, monitor or pump interface; not clinically validated.